Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.470
+0.050 (3.52%)
At close: Aug 14, 2025, 4:00 PM
1.450
-0.020 (-1.36%)
After-hours: Aug 14, 2025, 4:13 PM EDT
Cibus Market Cap
Cibus has a market cap or net worth of $73.14 million as of August 14, 2025. Its market cap has decreased by -68.86% in one year.
Market Cap
73.14M
Enterprise Value
293.02M
1-Year Change
-68.86%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since July 20, 2017, Cibus's market cap has decreased from $299.25M to $73.14M, a decrease of -75.56%. That is a compound annual growth rate of -16.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 68.71M | -6.58% |
| Dec 31, 2024 | 73.55M | -80.23% |
| Dec 29, 2023 | 372.10M | 5,065.15% |
| Dec 30, 2022 | 7.20M | -91.22% |
| Dec 31, 2021 | 82.02M | -47.56% |
| Dec 31, 2020 | 156.41M | -32.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 614.05B |
| Johnson & Johnson | 421.10B |
| AbbVie | 361.72B |
| UnitedHealth Group | 245.89B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Abbott Laboratories | 225.11B |
| Novo Nordisk | 225.09B |